India to Greece Pharmaceutical Export (2026) — $22.7M, 113 Suppliers | TransData Nexus

India to Greece Pharmaceutical Export (2026) — $22.7M, 113 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Greece

#	Formulation	Value	Share
1	Pharma Drugs & Medi Spirolactone 25mg 32000t Tlb(aco-europe As Per Invoice	$553.7K	2.4%
2	Doxcef 200mg X 10s Tablets Alkaloid Russia Cefpodoxime Proxetil Tablets 200mg O…	$521.0K	2.3%
3	Omeprazole Pellets 8.5%	$401.2K	1.8%
4	Contain Medicines Harmless Pharmaceuticals Product- Leuprol 11.25mg Injection (…	$332.7K	1.5%
5	Pharma Drugs Medi Spirolactone 25mg 32000t Tlb Aco Europe As Per Invoice	$283.3K	1.2%
6	Pharm Drug&med:bicalutamide 150mg 10x10t(accord-fi/se)each Film Coated Tablet C…	$220.9K	1.0%
7	Tridox 200mg - 10's Serbia Cefpodoxime Proxetil Tablets	$208.8K	0.9%
8	Lyvam(leve) Alkaloid 500mg 25x10 Serbia Levetiracetam Tablets 500 MG Other-anti…	$193.3K	0.9%
9	Forexo(cefpodoxime)suspension 8mg/ml - Ro Cefpodoxime Proxetil Oral Suspension…	$181.7K	0.8%
10	Omeprazole Pellets 8.5% (1 X 25 Kg)	$169.3K	0.7%
11	Massido Tablets 5 MG (r/m : Nebivolol Tablet) Batch Et446e5001 to Et446e5016 Ot…	$168.7K	0.7%
12	Pharma Drugs and Medi Matepil 400mg 3 X10 Tablets Each Film Coated Prolonged-re…	$165.6K	0.7%
13	Leuprol 11.25mg Injection (vial) Leuprolide Acetate (4000 Vials)	$165.1K	0.7%
14	Massido Tablets 5 MG (r/m : Nebivolol Tablet) Batch Et446e5017 to Et446e5021 Mf…	$160.8K	0.7%
15	Single Vaccines Other	$157.0K	0.7%

India exports 20+ pharmaceutical formulations to Greece with a combined trade value of $22.7M. Key products include Omeprazole ($401K), Cefpodoxime ($182K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 4,286 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Greece Trade Routes

1Omeprazole$401K

2Cefpodoxime$182K

These are the top pharmaceutical products exported from India to Greece, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Greece buyers, regulatory requirements, and logistics for that specific product corridor. Products include Omeprazole ($401K), Cefpodoxime ($182K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Greece

1Intas Pharmaceuticals Limited

$6.4M

2Lupin Limited

$2.3M

3Aurobindo Pharma Ltd

$1.1M

4Castle Rock Fisheries Private Limited

$882K

5Strides Pharma Science Limited

Port Analysis — India to Greece Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)5.6%

MUNDRA SEA2.7%

SAHAR AIR19.9%

SAHAR AIR CARGO ACC (INBOM4)10.1%

MUNDRA SEA (INMUN1)3.2%

Greece Import Ports

ATHENS70.8%

Piraeus7.9%

PIRAEUS5.3%

Skopje1.1%

Thessaloniki2.7%

Trade Statistics

Total Value$22.7M

Shipments4,286

Indian Exporters113

Greece Buyers174

Avg Shipment$5K

Products3,042

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Greece Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Greece has experienced significant growth over the past decade. In 2024, India exported pharmaceutical products valued at $16.38 million to Greece, marking a substantial increase from previous years. This upward trajectory reflects India's expanding presence in the European pharmaceutical market and Greece's growing reliance on imported medicines to meet its healthcare needs.

The bilateral trade has been characterized by a diverse range of pharmaceutical formulations, including tablets, capsules, syrups, and injections. This diversification indicates a robust demand for various dosage forms in Greece, aligning with the country's healthcare requirements. The consistent rise in export values underscores the strengthening economic ties and mutual trust between the two nations in the pharmaceutical sector.

2India's Market Position

India holds a significant position in Greece's pharmaceutical import landscape. In 2024, Greece imported pharmaceutical products worth $15.08 million from India, highlighting India's substantial share in Greece's total pharmaceutical imports. This positions India as a key supplier, offering a wide array of pharmaceutical formulations that cater to Greece's diverse medical needs.

The strategic importance of this trade is evident in the increasing number of Indian pharmaceutical companies entering the Greek market. The presence of 113 Indian exporters and 174 Greek buyers in 2024 indicates a dynamic and expanding trade relationship. This growth is driven by India's competitive pricing, adherence to international quality standards, and the ability to supply a broad spectrum of pharmaceutical products.

Greece Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Greece must comply with the European Medicines Agency (EMA) guidelines. The Common Technical Document (CTD) format is mandatory for dossier submissions, ensuring consistency and quality in the application process. Bioequivalence studies are required for generic products to demonstrate therapeutic equivalence to the reference medicine. The registration process typically spans several months, depending on the complexity of the product and the completeness of the submission.

The EMA evaluates applications based on scientific evidence, focusing on the safety, efficacy, and quality of the medicinal product. Once approved, the product is granted a marketing authorization, allowing it to be marketed and sold in Greece. This rigorous process ensures that only high-quality and effective pharmaceutical products are available to Greek patients.

2GMP & Facility Requirements

Greece mandates that pharmaceutical products imported from non-EU countries, including India, be manufactured in facilities adhering to Good Manufacturing Practice (GMP) standards. The National Organization for Medicines (EOF) oversees the inspection and certification of manufacturing sites to ensure compliance with these standards. Indian manufacturers must provide evidence of GMP certification from recognized authorities, such as the Central Drugs Standard Control Organisation (CDSCO) in India.

The EOF conducts inspections to verify that manufacturing processes meet the required quality standards. Mutual recognition agreements between the EMA and CDSCO facilitate the acceptance of GMP certifications, streamlining the approval process for Indian pharmaceutical products entering the Greek market. This collaboration enhances the efficiency of trade and ensures the availability of quality medicines to Greek consumers.

3Import Documentation

Importing pharmaceutical products into Greece requires specific documentation to ensure compliance with national and EU regulations. Key documents include the Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of GMP compliance. These documents verify the authenticity, quality, and safety of the pharmaceutical products.

The EOF mandates that importers obtain an import license for each batch of pharmaceutical products. This license is issued upon submission of the required documentation and after a thorough review process. Customs procedures involve detailed inspections and assessments to ensure that imported pharmaceuticals meet all regulatory standards before they enter the Greek market.

TransData Nexus Research · Greece regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Greece

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to Greece are predominantly composed of generic medicines, reflecting Greece's substantial demand for cost-effective therapeutic options. Therapeutic areas such as oncology, cardiology, and infectious diseases are particularly significant, aligning with Greece's healthcare priorities. The availability of high-quality generics from India provides Greek healthcare providers with affordable alternatives to branded medications, enhancing patient access to essential treatments.

The dominance of these categories is also influenced by Greece's aging population, which experiences a higher prevalence of chronic diseases. The need for long-term, cost-effective treatment options in these therapeutic areas drives the demand for generic medicines imported from India.

2Emerging Opportunities

The expiration of patents for several blockbuster drugs presents opportunities for Indian pharmaceutical companies to introduce generic versions in the Greek market. Additionally, the increasing demand for biosimilars in Europe offers a promising avenue for Indian exporters, given their expertise in biosimilar development. Expanding into new therapeutic areas, such as immunology and rare diseases, can further diversify India's export portfolio to Greece.

These emerging opportunities align with Greece's evolving healthcare needs and the European Union's emphasis on affordable healthcare solutions. Indian pharmaceutical companies can leverage these trends to strengthen their presence in the Greek market.

3Demand Drivers

Greece's aging population significantly contributes to the increased demand for pharmaceutical imports. The prevalence of age-related health conditions necessitates a steady supply of medications, particularly in therapeutic areas like cardiology, oncology, and neurology. Healthcare spending trends in Greece indicate a focus on cost-effective solutions, making generic medicines from India an attractive option.

Additionally, Greece's healthcare system faces challenges related to budget constraints, prompting a reliance on affordable pharmaceutical imports to meet the needs of its population. The demand for high-quality generics from India is expected to continue growing, driven by these demographic and economic factors.

TransData Nexus Research · DGFT trade data analysisMar 2026

Trade Policy & Tariff Intelligence — India and Greece

Tariff structure, trade agreements, IP and patent landscape

1Tariff & Duty Structure

Greece, as an EU member state, applies the EU's Most Favored Nation (MFN) tariff rates to pharmaceutical imports. Pharmaceutical formulations, including those from India, are subject to these standard rates. While the EU has preferential trade agreements with certain countries, India does not currently benefit from such agreements, resulting in standard MFN tariffs for Indian pharmaceutical exports.

Duty exemptions or reductions are not typically available for pharmaceutical formulations entering Greece. Indian exporters should account for these tariffs in their pricing strategies to maintain competitiveness in the Greek market.

2Trade Agreements

As of March 2026, there are no specific Free Trade Agreements (FTAs) between India and Greece concerning pharmaceutical products. The absence of such agreements means that Indian pharmaceutical exports to Greece are subject to standard EU import regulations and tariffs. Ongoing discussions at the EU level may influence future trade policies, but no significant changes have been implemented to date.

The lack of an FTA necessitates that Indian exporters navigate the EU's complex regulatory environment, including compliance with EMA guidelines and EOF requirements, to access the Greek market.

3IP & Patent Landscape

Greece adheres to EU regulations concerning intellectual property (IP) and patent laws. Patent provisions in Greece are aligned with EU directives, offering protection for pharmaceutical innovations. Data exclusivity periods are also in place, providing a window of protection for original products before generics can enter the market.

Compulsory licensing provisions exist but are rarely invoked, ensuring that patent holders maintain exclusive rights to their products. For Indian generic manufacturers, understanding and navigating Greece's IP landscape is crucial to avoid potential infringements and to strategize market entry effectively.

TransData Nexus Research · Trade policy databasesMar 2026

FAQ — India to Greece Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Greece?

India exported pharmaceuticals worth $22.7M to Greece across 4,286 verified shipments.

Who are the top Indian pharmaceutical exporters to Greece?

1. INTAS PHARMACEUTICALS LIMITED — $6.4M. 2. LUPIN LIMITED — $2.3M. 3. AUROBINDO PHARMA LTD — $1.1M. Total: 113 suppliers.

Which companies in Greece import pharmaceuticals from India?

1. ACCORD HEALTHCARE SINGLE MEMBER SA — $3.5M. 2. ALKALOID AD SKOPJE — $2.3M. 3. TO THE ORDER — $1.3M. 174 buyers total.

What pharmaceutical products does India export most to Greece?

1. Pharma Drugs & Medi Spirolactone 25mg 32000t Tlb(aco-europe As Per Invoice ($553.7K, 2.4%); 2. Doxcef 200mg X 10s Tablets Alkaloid Russia Cefpodoxime Proxetil Tablets 200mg O… ($521.0K, 2.3%); 3. Omeprazole Pellets 8.5% ($401.2K, 1.8%); 4. Contain Medicines Harmless Pharmaceuticals Product- Leuprol 11.25mg Injection (… ($332.7K, 1.5%); 5. Pharma Drugs Medi Spirolactone 25mg 32000t Tlb Aco Europe As Per Invoice ($283.3K, 1.2%)

Which ports handle pharmaceutical shipments from India to Greece?

Export: NHAVA SHEVA SEA (INNSA1), MUNDRA SEA, SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4), MUNDRA SEA (INMUN1). Import: ATHENS, Piraeus, PIRAEUS, Skopje, Thessaloniki.

Why does Greece import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $22.7M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Greece?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Greece pharmaceutical trade?

$5.3K per consignment across 4,286 shipments.

How many Indian pharmaceutical companies export to Greece?

113 Indian companies. Largest: INTAS PHARMACEUTICALS LIMITED with $6.4M.

How can I find verified Indian pharmaceutical suppliers for Greece?

TransData Nexus covers 113 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Greece identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 4,286 verified shipments from 113 Indian exporters to 174 Greece buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

113 Exporters

174 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Greece Pharmaceutical Export